10x Genomics (MEX:TXG) EV-to-EBIT : -10.87 (As of Oct. 31, 2024)

10x Genomics EV-to-EBIT Chart

10x Genomics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-EBIT	Get a 7-Day Free Trial															-21.14	-25.62	-16.40	-8.80	-13.76

Competitive Comparison of 10x Genomics's EV-to-EBIT

For the Health Information Services subindustry, 10x Genomics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

10x Genomics's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where 10x Genomics's EV-to-EBIT falls into.

10x Genomics EV-to-EBIT Calculation

10x Genomics's EV-to-EBIT for today is calculated as:

10x Genomics's current Enterprise Value is MXN33,781 Mil.
10x Genomics's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-3,107 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

10x Genomics  (MEX:TXG) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

10x Genomics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

10x Genomics's Enterprise Value for the quarter that ended in Sep. 2024 was MXN47,109 Mil.
10x Genomics's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-3,107 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

10x Genomics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of 10x Genomics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

10x Genomics Business Description